Clinical Trials Logo
  1. Home
  2. Chlamydia Trachomatis Infection
  3. NCT04269434

GonoScreen: Efficacy of Screening STIs in MSM — GonoScreen  

Chlamydia Trachomatis Infection Clinical Trial

Official title:
Does Screening for Gonorrhea and Chlamydia Affect the Incidence of These Infections in Men Who Have Sex With Men Taking HIV Pre Exposure Prophylaxis (PrEP): a Randomized, Multicentre Controlled Trial

Clinical Trial Summary

A Multicentre, controlled, randomized trial of 3 site (urethra, pharynx and rectum) sampling performed every 3 months (3x3) for Neisseria gonorrhoea (Ng)/Chlamydia trachomatis (Ct) screening (comparator) vs. no screening (intervention).

Clinical Trial Description

This study is a multicentre, controlled, randomized trial of 3x3 Ng/Ct screening (comparator) vs. no screening (intervention). It will be performed in the PrEP cohorts situated at the Institute of Tropical Medicine (ITM), Hôpital Saint-Pierre (HSP), Liège University Hospital (CHU), University Hospital of Gent (UZG) and Erasmus Hospital (EH). All men in follow up at these five centres who report having had sex with another man in the previous year and are enrolled for PrEP follow up will be eligible to participate in the study. After signing informed consent participants will be randomized via a computer-generated schema to either 3x3 screening or no Ng/Ct screening. In both arms, participants will be followed up in an identical fashion including 3x3 screening. The only difference between the arms will be that in the screening arm, Ng/Ct results will be sent by the STI Laboratory to the study physicians and these participants will be treated and partner contact tracing will be done. The Sexually Transmitted Infection (STI) Laboratory will only process the samples/report the results from the non-screening arm at the end of the study. In both arms, all individuals with symptoms compatible with Ng or Ct will be tested and treated for these infections according to current best practice guidelines. At the end of the 12-month study period, participants whose most recent tests were positive for Ng or Ct will receive treatment for these. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04269434
Study type Interventional
Source Institute of Tropical Medicine, Belgium
Contact
Status Completed
Phase N/A
Start date September 21, 2020
Completion date August 31, 2022
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04139629 - Cohort Study Investigating the Association Between Antichlamydial Antibody Positivity and ART Outcomes in Women With TFI N/A
Completed NCT03107377 - Phase 2B/3 Double-blinded Placebo-controlled Phase 2/Phase 3
Completed NCT03098329 - Check it: A New Approach to Controlling Chlamydia Transmission in Young People N/A
Recruiting NCT03862495 - Genital CT Treatment to Pregnant Women to Prevent Adverse Pregnancy Outcomes: A Pilot RCT N/A
Completed NCT05307991 - Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe
Terminated NCT02083276 - Mecillinam for Treatment of Genital Chlamydia Infection Phase 2
Active, not recruiting NCT06131749 - Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa
Completed NCT03568695 - Detection of Chlamydia Trachomatis, Neisseria Gonorrhoeae and Mycoplasma Genitalium by Real-time Multiplex Polymerase Chain Reaction (PCR) After Pooling Pharyngeal, Anorectal and Urinary Samples N/A
Completed NCT01448876 - Incubation Time and Test of Cure of Chlamydia Trachomatis N/A
Not yet recruiting NCT06369220 - A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections N/A
Not yet recruiting NCT06395675 - Clinical Evaluation of the ID NOW™ CT/NG Test N/A
Completed NCT03970850 - NeuMoDx PrEDiCTiNG Study Evaluation Plan N/A
Completed NCT01631201 - Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women Phase 2
Completed NCT05216744 - Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia Coinfection Phase 2
Recruiting NCT05581160 - Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST) N/A
Not yet recruiting NCT03532464 - Azithromycin Compared With Doxycycline for Treating Anorectal Chlamydia Trachomatis Infection Concomitant to a Vaginal Infection Phase 4
Not yet recruiting NCT06234943 - Pharmacy-based Testing and Treatment for Gonorrhea and Chlamydia N/A
Active, not recruiting NCT04050540 - Doxycycline PEP for Prevention of Sexually Transmitted Infections Among Kenyan Women Using HIV PrEP Phase 4
Completed NCT04955717 - Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences N/A
Recruiting NCT05666778 - Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs Phase 2